NCT02640352

The Efficacy of a Probiotic Product on Acute Upper Respiratory Tract Infections (Common Cold) in Healthy Children

A Randomized, Double Blind, Placebo-controlled Study to Investigate the Effect of a Probiotic Product on Acute Upper Respiratory Tract Infections (Common Cold) in Healthy Children

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 550 (actual)
• Sponsor: Probi AB · Industry
• Sex: All
• Age: 3 Years – 7 Years
• Healthy volunteers: Accepted

Summary

The aim of the present study is to test the efficacy of the combination of two probiotic bacteria in reducing the severity of upper respiratory tract infections (common cold) in healthy children attending day care or school. The probiotic bacteria used are Lactobacillus plantarum strain DSM 15312 and Lactobacillus paracasei DSM 13434 at a total dose of 1 x 10\^9 CFU/tablet and day and will be consumed for a period of 12 weeks.

Conditions

• Acute Upper Respiratory Tract Infections (Common Cold)

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Probi Defendum
DIETARY_SUPPLEMENT	Placebo

Timeline

• Start date: 2015-12-01
• Primary completion: 2017-06-01
• Completion: 2018-09-01
• First posted: 2015-12-28
• Last updated: 2018-10-17

Locations

1 site across 1 country: Italy